Cite Filings / BBIO / 0000950170-25-020045
Feed Companies Filings Check
Sign in
Cite Filings

Pages

  • Feed
  • Companies
  • Filings
  • Check a claim

Account

  • Sign in
  • Create an account
Support (opens in new tab)
SCHEDULE 13G/A

Statement of Beneficial Ownership

BridgeBio Pharma, Inc. · Filed 2025-02-13 · Acc 0000950170-25-020045

Documents 1

  • SCHEDULE 13G/A Statement of Beneficial Ownership , xslSCHEDULE_13G_X01/primary_doc.xml

Around this filing

  • 2025-07-29 SCHEDULE 13G/A Statement of Beneficial Ownership
  • 2025-02-19 144 Sale of Securities
  • 2025-02-19 144 Sale of Securities
  • 2025-02-19 4 President and COO gave up 13,782 shares (to pay taxes)
  • 2025-02-19 4 Secretary, Treasurer & CFO sold 4,148 shares at $36.16 ($149,973)
  • 2025-02-19 4 Chief Executive Officer sold 31,543 shares at an average $36.14 ($1,140,024)
  • 2025-02-13 SCHEDULE 13G/A Statement of Beneficial Ownership

Link to a passage

At least 12 characters, not counting spaces, so the link points to one passage.

External

  • SEC EDGAR (opens in new tab)
Loading xslSCHEDULE_13G_X01/primary_doc.xml…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…